{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:18:57Z","timestamp":1790893137372,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jaad.2019.04.035","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T19:45:59Z","timestamp":1555703159000},"page":"1371-1378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cholestatic pruritus: Emerging mechanisms and therapeutics"],"prefix":"10.1016","volume":"81","author":[{"given":"Sagar P.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Vasavda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Meixiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2019.04.035_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2340\/00015555-0662","article-title":"Epidemiology of itch: adding to the burden of skin morbidity","volume":"89","author":"Weisshaar","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"15","key":"10.1016\/j.jaad.2019.04.035_bib2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200868150-00006","article-title":"Pathogenesis and treatment of pruritus in cholestasis","volume":"68","author":"Kremer","year":"2008","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.035_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.26365","article-title":"Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study","volume":"58","author":"Mells","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cld.2012.11.006","article-title":"Advances in pathogenesis and treatment of pruritus","volume":"17","author":"Bolier","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.035_bib5","first-page":"548","article-title":"Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature","volume":"69","author":"Ebell","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2019.04.035_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0016-5085(19)35143-1","article-title":"Bile acids in the serum of jaundiced patients","volume":"41","author":"Carey","year":"1961","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.035_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/gut.31.1.96","article-title":"Raised histamine concentrations in chronic cholestatic liver disease","volume":"31","author":"Gittlen","year":"1990","journal-title":"Gut"},{"issue":"3 Pt 1","key":"10.1016\/j.jaad.2019.04.035_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","article-title":"Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study","volume":"41","author":"Bergasa","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"10.1016\/j.jaad.2019.04.035_bib9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0024-3205(93)90569-O","article-title":"Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys","volume":"53","author":"Bergasa","year":"1993","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.035_bib10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","article-title":"Lysophosphatidic acid is a potential mediator of cholestatic pruritus","volume":"139","author":"Kremer","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.035_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000078632","article-title":"Itch-scratch responses induced by lysophosphatidic acid in mice","volume":"72","author":"Hashimoto","year":"2004","journal-title":"Pharmacology"},{"issue":"6662","key":"10.1016\/j.jaad.2019.04.035_bib12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"BMJ"},{"issue":"Suppl. 2","key":"10.1016\/j.jaad.2019.04.035_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000440829","article-title":"Pathogenesis and management of pruritus in PBC and PSC","volume":"33","author":"Kremer","year":"2015","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"issue":"20","key":"10.1016\/j.jaad.2019.04.035_bib15","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1523\/JNEUROSCI.17-20-08003.1997","article-title":"Specific C-receptors for itch in human skin","volume":"17","author":"Schmelz","year":"1997","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.jaad.2019.04.035_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.dld.2010.03.015","article-title":"Bile salts and cholestasis","volume":"42","author":"Wenniger","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.jaad.2019.04.035_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000086667","article-title":"Antihistamines in dermatology","volume":"18","author":"Greaves","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"issue":"4","key":"10.1016\/j.jaad.2019.04.035_bib18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI64551","article-title":"The TGR5 receptor mediates bile acid\u2013induced itch and analgesia","volume":"123","author":"Alemi","year":"2013","journal-title":"J Clin Invest"},{"issue":"5946","key":"10.1016\/j.jaad.2019.04.035_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.4.5946.693","article-title":"Pruritic effect of bile salts","volume":"4","author":"Kirby","year":"1974","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.jaad.2019.04.035_bib20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2036.2012.04994.x","article-title":"\u2018Out-patient\u2019 albumin dialysis for cholestatic patients with intractable pruritus","volume":"35","author":"Leckie","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jaad.2019.04.035_bib21","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.25748","article-title":"Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions","volume":"56","author":"Kremer","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jaad.2019.04.035_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2016.03.019","article-title":"Autotaxin, pruritus and primary biliary cholangitis (PBC)","volume":"15","author":"Sun","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.jaad.2019.04.035_bib23","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1136\/gut.30.10.1392","article-title":"Plasma leucine enkephalin is increased in liver disease","volume":"30","author":"Thornton","year":"1989","journal-title":"Gut"},{"issue":"8-9","key":"10.1016\/j.jaad.2019.04.035_bib24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2340\/00015555-2704","article-title":"Involvement of \u03bc-opioid Receptors and \u03ba-opioid receptors in itch-related scratching behaviour of imiquimod-induced psoriasis-like dermatitis in mice","volume":"97","author":"Takahashi","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.04.035_bib25","doi-asserted-by":"crossref","first-page":"e44116","DOI":"10.7554\/eLife.44116","article-title":"Identification of a bilirubin receptor may mediate a component of cholestatic itch","volume":"8","author":"Meixiong","year":"2019","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.jaad.2019.04.035_bib26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cell.2009.11.034","article-title":"Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus","volume":"139","author":"Liu","year":"2009","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jaad.2019.04.035_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(01)00483-4","article-title":"A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons","volume":"106","author":"Dong","year":"2001","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jaad.2019.04.035_bib28","first-page":"599","article-title":"Relief of pruritus by cholestyramine in chronic liver disease","volume":"1","author":"Oster","year":"1965","journal-title":"Isr J Med Sci"},{"issue":"12","key":"10.1016\/j.jaad.2019.04.035_bib29","first-page":"773","article-title":"Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra-and extra-hepatic cholestasis: relationship between itching and serum bile acids","volume":"6","author":"Di Padova","year":"1984","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"6436","key":"10.1016\/j.jaad.2019.04.035_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.289.6436.22","article-title":"Treatment of pruritus due to chronic obstructive liver disease","volume":"289","author":"Duncan","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"7","key":"10.1016\/j.jaad.2019.04.035_bib31","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","article-title":"The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus","volume":"102","author":"Tandon","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/CRIAI:28:2:147","article-title":"Extrahepatic manifestations of cholestatic liver diseases","volume":"28","author":"Pusl","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.035_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12876-016-0481-9","article-title":"BAT117213: ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial","volume":"16","author":"Hegade","year":"2016","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"10.1016\/j.jaad.2019.04.035_bib34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"issue":"8638","key":"10.1016\/j.jaad.2019.04.035_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"333","author":"Bachs","year":"1989","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01300759","article-title":"Treatment of pruritus of primary biliary cirrhosis with rifampin","volume":"36","author":"Podesta","year":"1991","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jaad.2019.04.035_bib38","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.035_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaad.2019.04.035_bib40","first-page":"1022","article-title":"Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease","volume":"91","author":"Carson","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jaad.2019.04.035_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1742-1241.1994.tb09854.x","article-title":"Buprenorphine and hepatic pruritus","volume":"48","author":"Juby","year":"1994","journal-title":"Br J Clin Pract"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.035_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2125.1980.tb01742.x","article-title":"Naloxone modulates the perception of itch in man","volume":"10","author":"Summerfield","year":"1980","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2019.04.035_bib44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","article-title":"Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study","volume":"37","author":"Terg","year":"2002","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.04.035_bib45","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0016-5085(03)00879-5","article-title":"Pain as a complication of use of opiate antagonists for symptom control in cholestasis","volume":"125","author":"Mcrae","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.035_bib47","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2019.04.035_bib48","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1572-0241.2003.08662.x","article-title":"Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis","volume":"98","author":"Browning","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.035_bib49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MPG.0000000000001385","article-title":"Sertraline as an additional treatment for cholestatic pruritus in children","volume":"64","author":"Th\u00e9baut","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.jaad.2019.04.035_bib50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jhep.2012.04.023","article-title":"Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study","volume":"57","author":"Decock","year":"2012","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.04.035_bib51","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","article-title":"Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease","volume":"97","author":"Neff","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2010.02.031","article-title":"Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers","volume":"53","author":"Par\u00e9s","year":"2010","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.04.035_bib53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/liv.13281","article-title":"Plasmapheresis exerts a long-lasting antipruritic effect in severe cholestatic itch","volume":"37","author":"Krawczyk","year":"2017","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/apt.13449","article-title":"The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study","volume":"43","author":"Hegade","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jaad.2019.04.035_bib55","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12072-016-9775-9","article-title":"Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease","volume":"11","author":"Kittanamongkolchai","year":"2017","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.035_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ajg.2017.287","article-title":"Effects of bezafibrate on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response","volume":"113","author":"Reig","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jaad.2019.04.035_bib57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13063-017-1966-8","article-title":"Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial","volume":"18","author":"Bolier","year":"2017","journal-title":"Trials"},{"issue":"10074","key":"10.1016\/j.jaad.2019.04.035_bib58","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","article-title":"Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study","volume":"389","author":"Hegade","year":"2017","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.jaad.2019.04.035_bib59","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaad.2019.04.035_bib60","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00004836-199004000-00012","article-title":"Failure of rifampin to relieve pruritus in chronic liver disease","volume":"12","author":"Woolf","year":"1990","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.jaad.2019.04.035_bib61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2010.02.031","article-title":"Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers","volume":"53","author":"Par\u00e9s","year":"2010","journal-title":"J Hepatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219306279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219306279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:53:36Z","timestamp":1759272816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219306279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0190962219306279"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.04.035","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholestatic pruritus: Emerging mechanisms and therapeutics","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}